* Intensive Care Unit, The Third Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210001, P. R. China.
† Nanjing University of Chinese Medicine, Nanjing 210029, P. R. China.
Am J Chin Med. 2018;46(3):567-583. doi: 10.1142/S0192415X18500295. Epub 2018 Mar 29.
Angiogenesis is a process of new blood vessel formation from pre-existing vessels. Vascular endothelial growth factor-A (VEGF-A) binds to VEGF receptor-2 (VEGFR2) and thus activation of phosphatidylinositol 3-kinase (PI3K)/Akt pathway play a central role in angiogenesis. Total flavones of Abelmoschus manihot (TFA), the major active component of the traditional Chinese herb Abelmoschus manihot, display novel pro-angiogenic activity. However, little information concerning its underlying mechanism is available. Here we investigate the pro-angiogenesis of TFA with the aim of understanding its mechanism of action. Human umbilical vein endothelial cells (HUVECs) and the chick chorioallantoic membrane (CAM) model were used to evaluate pro-angiogenesis of TFA using cell viability, wounding healing, transwell invasion, tube formation, RT-qPCR and Western blot methods. LY294002, a PI3K inhibitor, was used to interfere with PI3K/Akt pathway signal for assessing the underlying mechanism. Results in vitro indicated TFA obviously promoted HUVECs proliferation, migration, invasion and tube formation. Furthermore, TFA markedly augmented PI3K and Akt phosphorylation and up-regulated VEGF-A and VEGFR2 expression in HUVECs. However, pre-treatment with LY294002 not only markedly attenuated TFA-induced cells proliferation, migration, invasion and tube formation, but also significantly abolished TFA-induced VEGF-A and VEGFR2 over-expression as well as PI3K and Akt phosphorylation. Experiments in CAM model showed TFA significantly promoted the formation of branched blood vessels and was dramatically suppressed by LY294002. Taken together, TFA promoted angiogenesis both in vitro and in vivo which, however, were counteracted by LY294002, suggesting at least in part, TFA exhibits pro-angiogenic activity by activating the VEGF-A/VEGFR2-PI3K/Akt signaling axis.
血管生成是指从预先存在的血管中形成新的血管的过程。血管内皮生长因子-A(VEGF-A)与血管内皮生长因子受体-2(VEGFR2)结合,从而激活磷脂酰肌醇 3-激酶(PI3K)/Akt 途径在血管生成中发挥核心作用。黄蜀葵花总黄酮(TFA)是传统中药黄蜀葵的主要活性成分,具有新的促血管生成活性。然而,关于其潜在机制的信息很少。在这里,我们研究了 TFA 的促血管生成作用,旨在了解其作用机制。用人脐静脉内皮细胞(HUVEC)和鸡胚尿囊膜(CAM)模型,通过细胞活力、划痕愈合、Transwell 侵袭、管形成、RT-qPCR 和 Western blot 方法评估 TFA 的促血管生成作用。LY294002 是一种 PI3K 抑制剂,用于干扰 PI3K/Akt 信号通路以评估潜在机制。体外结果表明,TFA 明显促进 HUVEC 增殖、迁移、侵袭和管形成。此外,TFA 明显增加了 HUVEC 中 PI3K 和 Akt 的磷酸化,并上调了 VEGF-A 和 VEGFR2 的表达。然而,LY294002 的预处理不仅明显减弱了 TFA 诱导的细胞增殖、迁移、侵袭和管形成,而且显著消除了 TFA 诱导的 VEGF-A 和 VEGFR2 过表达以及 PI3K 和 Akt 的磷酸化。CAM 模型实验表明,TFA 明显促进了分支血管的形成,而 LY294002 则显著抑制了这一过程。总之,TFA 促进了体内外的血管生成,而 LY294002 则拮抗了这一过程,这表明 TFA 至少部分通过激活 VEGF-A/VEGFR2-PI3K/Akt 信号通路发挥促血管生成活性。